Articles

On December 10, 2021, a Common Vulnerability and Exposure (CVE) alert was issued from NIST related to Apache Log4j, CVE-2021-44228.

Tucked inside the bill that President Biden signed to raise the national debt ceiling was a holiday gift for clinical laboratories and Medicare patients.

ARUP Consult® has released updated resources on Hereditary Thrombophilia, Group B Streptococcal Disease, and Paraneoplastic Neurologic Syndromes (PNSs).

ARUP Laboratories has successfully completed the second surveillance assessment of its College of American Pathologists (CAP) International Organization for Standardization (ISO) 15189 accreditation.

ARUP Consult released new and updated resources on genetic cardiovascular disease, the effects of common anticoagulants on coagulation testing, laboratory testing for primary sclerosing cholangitis.

Deep Bio, a leading company in artificial intelligence (AI) cancer diagnostics, announced it obtained an approval from the University of IRB for a real-world implementation study.

Managing the challenge of a global healthcare crisis such as the COVID-19 pandemic requires collaboration, clear and abundant communication, and planning to allow a healthcare system to adapt.

About 200 research park and innovation district leaders from around the globe visited ARUP to hear how Research Park’s largest tenant has become a model for startups born in research institutions.

ARUP Consult® added new resources in September that provide expert guidance on preoperative testing for ovarian cancer biomarkers and testing strategies for malaria.

SALT LAKE CITY—The University of Utah Department of Pathology and ARUP Laboratories today announced the creation of the Harry R.

Harry R. Hill, MD, has been the force behind many firsts at ARUP Laboratories and the University of Utah.

AirMed and ARUP Blood Services commemorate a yearlong partnership in which ARUP has provided blood for AirMed to transfuse patients in flight.